An immediate, single instillation of mitomycin C in non-muscle invasive bladder cancer: can we define which patients do and do not benefit?

Por Bosschieter, Judith, van Moorselaar, R. Jeroen A., Nieuwenhuijzen, Jakko A.
Publicado no Transl Androl Urol (2019)

Prostate Cancer Development Is Not Affected by Statin Use in Patients with Elevated PSA Levels

Por Meijer, Dennie, van Moorselaar, R. Jeroen A., Vis, André N., Bijnsdorp, Irene V.
Publicado no Cancers (Basel) (2019)

Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients

Por Bijnsdorp, Irene V., Geldof, Albert A., Lavaei, Mehrdad, Piersma, Sander R., van Moorselaar, R. Jeroen A., Jimenez, Connie R.
Publicado em 2013

Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance

Por van Spaendonck-Zwarts, Karin Y., Badeloe, Sadhanna, Oosting, Sjoukje F., Hovenga, Sjoerd, Semmelink, Harry J. F., van Moorselaar, R. Jeroen A., van Waesberghe, Jan Hein, Mensenkamp, Arjen R., Menko, Fred H.
Publicado em 2011

The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer

Por Tetar, Shyama U., Bohoudi, Omar, Senan, Suresh, Palacios, Miguel A., Oei, Swie S., van der Wel, Antoinet M., Slotman, Berend J., van Moorselaar, R. Jeroen A., Lagerwaard, Frank J., Bruynzeel, Anna M. E.
Publicado no Cancers (Basel) (2020)

A systematic review on mutation markers for bladder cancer diagnosis in urine

Por Hentschel, Anouk E., van der Toom, Emma E., Vis, André N., Ket, Johannes C.F., Bosschieter, Judith, Heymans, Martijn W., van Moorselaar, R. Jeroen A., Steenbergen, Renske D.M., Nieuwenhuijzen, Jakko A.
Publicado no BJU Int (2020)

Spontaneous pneumothorax as indicator for Birt-Hogg-Dubé syndrome in paediatric patients

Por Johannesma, Paul C, van den Borne, Ben EEM, Gille, Johannes JP, Nagelkerke, Ad F, van Waesberghe, JanHein TM, Paul, Marinus A, van Moorselaar, R Jeroen A, Menko, Fred H, Postmus, Pieter E
Publicado em 2014

Comparative Analysis of Urine Fractions for Optimal Bladder Cancer Detection Using DNA Methylation Markers

Por Hentschel, Anouk E., Nieuwenhuijzen, Jakko A., Bosschieter, Judith, van Splunter, Annina P., Lissenberg-Witte, Birgit I., van der Voorn, J. Patrick, Segerink, Loes I., van Moorselaar, R. Jeroen A., Steenbergen, Renske D.M.
Publicado no Cancers (Basel) (2020)

Are lung cysts in renal cell cancer (RCC) patients an indication for FLCN mutation analysis?

Por Johannesma, Paul C., Houweling, Arjan C., Menko, Fred H., van de Beek, I., Reinhard, Rinze, Gille, Johan J. P., van Waesberghe, JanHein T. M., Thunnissen, Erik, Starink, Theo M., Postmus, Pieter E., van Moorselaar, R. Jeroen A.
Publicado no Fam Cancer (2015)

Confocal Laser Endomicroscopy and Optical Coherence Tomography for the Diagnosis of Prostate Cancer: A Needle-Based, In Vivo Feasibility Study Protocol (IDEAL Phase 2A)

Por Swaan, Abel, Mannaerts, Christophe K, Scheltema, Matthijs JV, Nieuwenhuijzen, Jakko A, Savci-Heijink, C Dilara, de la Rosette, Jean JMCH, van Moorselaar, R Jeroen A, van Leeuwen, Ton G, de Reijke, Theo M, de Bruin, Daniel Martijn
Publicado no JMIR Res Protoc (2018)

Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment

Por de Nie, Iris, de Blok, Christel J M, van der Sluis, Tim M, Barbé, Ellis, Pigot, Garry L S, Wiepjes, Chantal M, Nota, Nienke M, van Mello, Norah M, Valkenburg, Noelle E, Huirne, Judith, Gooren, Louis J G, van Moorselaar, R Jeroen A, Dreijerink, Koen M A, den Heijer, Martin
Publicado no J Clin Endocrinol Metab (2020)